SEC Form 4 research
| Issuer | Travere Therapeutics, Inc. |
|---|---|
| Tickers | RTRX, TVTX, DGTE |
| Reporting owners | 34 |
| Officers and directors | 21 |
| Last public filing | 2026-09-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-15 | ROTE WILLIAM E. | S | 270 | $65.31 | Not reported |
| 2026-09-17 | 2026-09-15 | ROTE WILLIAM E. | S | 3,000 | $63.65 | Not reported |
| 2026-09-17 | 2026-09-15 | ROTE WILLIAM E. | S | 29,021 | $62.66 | Not reported |
| 2026-09-17 | 2026-09-15 | ROTE WILLIAM E. | S | 63,907 | $61.99 | Not reported |
| 2026-09-17 | 2026-09-16 | ROTE WILLIAM E. | S | 47,746 | $63.61 | Not reported |
| 2026-09-17 | 2026-09-16 | ROTE WILLIAM E. | S | 65,104 | $63.12 | Not reported |
| 2026-09-17 | 2026-09-15 | Heerma Peter | S | 1,431 | $65.31 | Not reported |
| 2026-09-17 | 2026-09-15 | Heerma Peter | S | 1,400 | $63.65 | Not reported |
| 2026-09-17 | 2026-09-15 | Heerma Peter | S | 27,421 | $62.59 | Not reported |
| 2026-09-17 | 2026-09-15 | Heerma Peter | S | 71,938 | $62.05 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.